After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NMRA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Neumora Therapeutics Inc is $394.33M. A total of 1.2 million shares were traded on the day, compared to an average of 1.41M shares.
In the most recent transaction, Aurora Daljit Singh sold 114,703 shares of NMRA for 2.68 per share on Nov 11 ’25. After the transaction, the insider now owns 0 company shares. In a previous transaction on Nov 11 ’25, Aurora Family Trust bought 114,703 shares at 2.68 per share.
Among the insiders who bought shares, Burow Kristina acquired of 1,915,700 shares on Oct 27 ’25 at a per-share price of $2.61. This resulted in the Director holding 6,046,907 shares of NMRA after the transaction. In another insider transaction, ARCH Venture Partners XII, LLC bought 1,915,700 shares at $2.61 per share on Oct 27 ’25. Company shares held by the 10% Owner now total 6,046,907.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NMRA has a high of $11.57 and a low of $0.61.
As of this writing, NMRA has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.37. The company reported an EPS of -$0.37 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NMRA’s latest balance sheet shows that the firm has $409.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.05M in debt and $23.28M in liabilities at the time. Its Book Value Per Share was $0.82, while its Total Shareholder’s Equity was -$325.22M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NMRA is Buy with a score of 3.56.
